Tonix Pharmaceuticals Holding Corp. (TNXP) has a negative trailing P/E of -0.9, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -111.02%.
Criteria proven by this page:
Overall SharesGrow Score: 49/100 with 2/7 criteria passed.
| Year | P/E (TTM) | PEG Ratio | P/B Ratio | P/S Ratio | Dividend Yield |
|---|---|---|---|---|---|
| 2016 | -25,171.5 | 412.40 | 38,551.72 | 0.00 | - |
| 2017 | -68,112.3 | 934.60 | 58,447.19 | 0.00 | - |
| 2018 | -38,971.2 | 585.49 | 48,343.48 | 0.00 | 0.00% |
| 2019 | -21,042.2 | 267.72 | 63,946.58 | 0.00 | - |
| 2020 | -21,919.7 | -712.12 | 12,620.21 | 0.00 | 0.00% |
| 2021 | -1.4 | 0.00 | 0.59 | 0.00 | - |
| 2022 | -217.1 | 2.18 | 115.48 | 0.00 | - |
| 2023 | -20.2 | -0.03 | 22.38 | 304.09 | - |
| 2024 | -0.6 | 0.01 | 0.53 | 7.40 | - |
| 2025 | -1.1 | 0.01 | 0.54 | 10.14 | - |
| Year | EPS (Diluted) | Revenue | Net Income | Net Margin |
|---|---|---|---|---|
| 2016 | $-199,190.00 | $0.00 | $-38.84M | - |
| 2017 | $-54,023.00 | $0.00 | $-21.12M | - |
| 2018 | $-18,064.60 | $0.00 | $-29.36M | - |
| 2019 | $-3,866.00 | $0.00 | $-31.09M | - |
| 2020 | $-5,056.00 | $2.91M | $-52.17M | -1790.5% |
| 2021 | $-1,666.00 | $0.00 | $-92.29M | - |
| 2022 | $-811.68 | $9.03M | $-116.88M | -1294.7% |
| 2023 | $-6,368.84 | $7.77M | $-116.66M | -1501.8% |
| 2024 | $-3,504.00 | $10.09M | $-130.04M | -1288.3% |
| 2025 | $-14.57 | $13.11M | $-124.02M | -946.2% |
| Year | EPS (Avg) | EPS Range | Revenue (Avg) | Revenue Range | Analysts |
|---|---|---|---|---|---|
| 2026 | $-9.28 | $-11.17 – $-7.42 | $58.95M | $30.32M – $96.44M | 2 |
| 2027 | $-4.43 | $-5.16 – $-3.69 | $116.95M | $101.4M – $132.5M | 1 |
| 2028 | $-0.84 | $-1.02 – $-0.69 | $214.53M | $185.03M – $249.38M | 1 |
